Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...

The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

In the early, uncertain days of the coronavirus pandemic, scientists delivered one comforting pronouncement: The virus that ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, according to a study published in Nature. Using population-wide data ...

Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the company ...

For some, the symptoms never went away. The omicron relative now dominant in the U.S. is called XEC, which accounted for 45% of variants circulating nationally in the two-week period ending Dec ...

New Covid variant JN.1 becomes the most common strain on Earth - symptoms to look out for ...

Please log in, or sign up for a new account and purchase a subscription to continue reading. BEST VALUE! Like never before, the Daily News delivers real value every ...

Cases of diarrhea, which may or may not be related to new COVID variant JN.1, are reportedly on the rise. © 2025 Fortune Media IP Limited. All Rights Reserved. Use ...